MSTN and muscular dystrophy: The ability of follistatin to prevent muscle wasting in cachexia and fibrosis in mouse models of muscular dystrophy probably involves interference with myostatin signaling via the pathway, although the relative contributions of endogenous activin and myostatin have not been well characterized in these models [25,26,27].